Prostate cancer trials in United States

In United States 655 Also abroad 1490

655 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer
Where
Salt Lake City
Age
18 years and over
People
32
Run by
University of Utah
See details and how to joinNCT06568562
No phaseTaking people
Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital
Where
Houston
Age
18 years and over
People
60
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT07591701
No phaseTaking people
A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Darolutamide
Where
Whippany
Age
55 years and over
People
3,000
Run by
Bayer
See details and how to joinNCT07672119
Phase 1/2Taking people
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Where
Basking Ridge, Commack, Durham, Harrison, Middletown, Montvale, New Haven, New York, Philadelphia, Portland, Uniondale
Age
18 years and over
People
50
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06457919
Phase 2Taking people
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Where
Atlanta, Boston, Charlotte, Cleveland, Encinitas, Grand Rapids, Harvey, Jacksonville, Lake Success, Los Angeles, Morristown, Tucson, Whittier
Age
18 years and over
People
37 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT04641247 · EU 2023-506618-29-00
Phase 2Taking people
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
Where
Houston
Age
18 years and over
People
200
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT04947254
Phase 2Taking people
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
Where
Chicago, Columbus, Houston, Jacksonville, Lake Success, Lisle, Little Rock, Miami, Milwaukee, Murray, New York, Omaha, Philadelphia, Phoenix, Pittsburgh, Sacramento, Shreveport, St Louis, Tampa, Troy, Tucson, Wichita
Age
18 years and over
People
91
Run by
Syncromune, Inc.
See details and how to joinNCT06533644
No phaseTaking people
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
Where
Detroit
Age
20 years to 79 years
People
85
Run by
Barbara Ann Karmanos Cancer Institute
See details and how to joinNCT07436078
No phaseTaking people
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
Where
Chapel Hill
Age
18 years and over
People
207
Run by
UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07463833
Phase 2Taking people
A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
Where
Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
Age
18 years and over
People
54
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07635238
No phaseTaking people
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
Where
Fairfax, Flint, Jacksonville, Little Rock, St Louis, Warrenville
Age
18 years and over
People
70
Run by
Proton Collaborative Group
See details and how to joinNCT00969111
Phase 2Taking people
Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation
Where
Chicago
Age
18 years and over
People
57
Run by
University of Chicago
See details and how to joinNCT05790213
Phase 2Taking people
PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer
Where
Miami
Age
18 years and over
People
34
Run by
University of Miami
See details and how to joinNCT06392295
Phase 3Taking people
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
Where
Dallas
Age
40 years to 89 years
People
291
Run by
University of Texas Southwestern Medical Center
See details and how to joinNCT03769766
Phase 1Taking people
Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy
Where
Los Angeles
People
30
Run by
Jonsson Comprehensive Cancer Center
See details and how to joinNCT05398302
Phase 2Taking people
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Where
Ann Arbor, Houston, Los Angeles, New York, Philadelphia, Portland, Salisbury, Seattle, St Louis, Tampa, The Bronx, Wappingers Falls
Age
18 years and over
People
192
Run by
Sun Pharmaceutical Industries Limited
See details and how to joinNCT05422911
Phase 1/2Taking people
HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
Where
Charlottesville
Age
18 years and over
People
23
Run by
University of Virginia
See details and how to joinNCT07441889
No phaseTaking people
Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
Where
Ann Arbor
Age
35 years to 70 years
People
200
Run by
University of Michigan Rogel Cancer Center
See details and how to joinNCT07645391
Phase 1Taking people
Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer
Where
Brooklyn, New York
Age
18 years to 99 years
People
42
Run by
Weill Medical College of Cornell University
See details and how to joinNCT04886986
Phase 1Taking people
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Where
Chicago, Glen Burnie, Iowa City, Lexington, Omaha, Pittsburgh
Age
18 years and over
People
48
Run by
Orano Med Theranostics, SAS
See details and how to joinNCT05283330
Phase 1Taking people
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
Where
New York
Age
18 years and over
People
16
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04167969
Phase 2Taking people
Using FAPI PET/MRI to Evaluate Prostate Cancer
Where
Madison
Age
18 years and over
People
30
Run by
University of Wisconsin, Madison
See details and how to joinNCT06675357
No phaseTaking people
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
Where
Rochester
Age
18 years to 85 years
People
147
Run by
Mayo Clinic
See details and how to joinNCT06788886
Phase 1Taking people
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Where
Fort Worth, Los Angeles, West Valley City
Age
18 years and over
People
40
Run by
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT07517198
No phaseTaking people
A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)
Where
Charlottesville
Age
18 years and over
People
18
Run by
University of Virginia
See details and how to joinNCT07535541